Core Laboratories Inc. (CLB)

Core Laboratories Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	24.35	29.67	31.4	36.68	19.45	19.73
Depreciation & Amortization	14.85	14.65	14.95	15.78	17.16	18.52
Loss (Gain) From Sale of Assets	-	-	-	-	-	-1.01
Asset Writedown & Restructuring Costs	0.03	0.03	1.11	1.14	-	-
Stock-Based Compensation	8.37	7.14	3.76	13.97	7.76	19.09
Provision & Write-off of Bad Debts	1.91	3.42	1.2	0.18	-0.01	-0.26
Other Operating Activities	-1.43	-3.34	-3.91	-14.19	5.61	1.07
Change in Accounts Receivable	3.38	-4.95	-3.61	-2.62	-10.08	-13.52
Change in Inventory	0.74	2.64	9.37	-12.98	-14.86	-4.55
Change in Accounts Payable	-2.91	0.48	0.52	-12.88	15.37	6.57
Change in Unearned Revenue	-4.04	-3.78	4.58	-1.19	-1.82	2.31
Change in Other Net Operating Assets	-17.04	-8.92	-2.97	0.89	-13.63	-11.37
Operating Cash Flow	28.22	37.03	56.39	24.79	24.96	36.58
Operating Cash Flow Growth	-48.02%	-34.33%	127.47%	-0.67%	-31.77%	-36.79%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-17.34	-14.59	-13.03	-10.58	-10.22	-13.54
Sale of Property, Plant & Equipment	3.89	3.02	1.74	0.49	1.89	0.68
Cash Acquisitions	-0.62	-1.24	-	-	-	-
Divestitures	-	-	-	-	0.24	0.87
Sale (Purchase) of Intangibles	-0.14	-0.15	0.02	0.07	-0.03	-0.32
Other Investing Activities	5.53	10.73	4.88	3.38	4.26	2.08
Investing Cash Flow	-8.68	-2.23	-6.39	-6.65	-3.86	-10.22

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	48	44	202	116	155
Long-Term Debt Repaid	-	-63	-82	-211	-131	-226
Net Debt Issued (Repaid)	-9.63	-15	-38	-9	-15	-71
Issuance of Common Stock	-	-	-	-	-	60
Repurchase of Common Stock	-14.35	-12.43	-5.31	-2.2	-3.9	-8.26
Common Dividends Paid	-1.85	-1.87	-1.88	-1.87	-1.85	-1.83
Other Financing Activities	-2.17	-1.96	-0.78	-5.38	-2.62	-1.37
Financing Cash Flow	-27.99	-31.26	-45.96	-18.45	-23.38	-22.46

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	-8.45	3.55	4.04	-0.31	-2.28	3.9

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	10.88	22.44	43.36	14.21	14.74	23.04
Free Cash Flow Growth	-72.30%	-48.24%	205.14%	-3.60%	-36.02%	-49.90%
Free Cash Flow Margin	2.10%	4.26%	8.28%	2.79%	3.01%	4.90%
Free Cash Flow Per Share	0.23	0.48	0.91	0.30	0.32	0.49
Levered Free Cash Flow	36.01	45.78	50.21	21.2	22.42	24.66
Unlevered Free Cash Flow	42.88	52.39	57.94	29.59	29.65	30.38

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	8.43	8.18	10.86	11.2	9.3	10.48
Cash Income Tax Paid	20.41	18.74	17.58	14.54	14.08	9.07
Change in Working Capital	-19.87	-14.53	7.88	-28.77	-25.02	-20.56

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 1, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error